We love Fast Company over here. Their ability to curate the technology world and find the signal from the noise is rivaled by a only handful of other publications.
We love it even more when they write about us – which they did twice this month.
The first article covers the extraordinary research conducted by Adam Ferguson and the team over at UCSF. UCSF has been a longtime collaborator and has produced superb results on everything from mild traumatic brain injury to spinal cord injuries.
Fast Company profiles an interesting angle in the recent Nature Communications paper on spinal cord in rats. While the research is fascinating, the angle Fast Company picked up on is the concept of “dark data” and what it could potentially mean for science. There are petabytes of this dark data and it hides untold secrets – yet the technologies to extract insight from it didn’t exist when it was collected. This changes with the advent of topological data analysis and it has profound implications for how we value and utilize that data. Take the jump to the actual article for a full read.
The second article covers another breakthrough – this one performed by the Icahn Institute at Mt. Sinai and published in Science: Translational Medicine. Using Ayasdi software, the team at Mt. Sinai was able to definitively identify multiple subtypes of diabetes. This has major implications for precision medicine – a field that struggled to deliver against its weighty expectations in recent years. While our technology is the story, not the pictures, we don’t mind all the attention – on the cover of the magazine to the Icahn Institute webpage. Here is a link to the second piece.
Both of these stories underscore the impact that Ayasdi is having in the world. Plenty of companies like to talk about making a difference – but we are; one collaborator and one prestigious journal at a time. It is but one of the reasons that the World Economic Forum recognized us as one of their Technology Pioneers in 2015.